GLYCOMICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

The global glycomics market is estimated to be valued at USD 1.99 BN in 2024 and is expected to exhibit a CAGR of 13.5% during the forecast period (2024-2031). Glycomics is the large-scale study of the entire complement of sugars, known as the glycome. Glycomics seeks to understand the synthesis and function of sugars in biological processes. Sugars are essential building blocks of all living things and serve structural or functional roles in proteins and lipids. Glycomics focuses on characterizing the structure, function, and interactions of glycans, which are sugars or sugar chains that attach to proteins and lipids. Understanding glycans is important as they influence key biological mechanisms including cell-cell communication, cell development, immune response, and disease pathogenesis. Advancements in analytical technologies, such as mass spectrometry and microarrays, have enabled high-throughput glycomic profiling and hold promise for widespread applications in biomedicine.

Market Dynamics:

The global glycomics market is driven by factors such as increasing research on glycosylation and its roles in diseases, growing initiatives by government and private organizations to support glycomics research, and rising applications of glycans in developing diagnostics, biomarkers, and therapeutics for cancer and other conditions. However, the market growth can be restrained by technical challenges in glycomic analysis due to the structural complexity of glycans and lack of standardized profiling methods. Major opportunities include partnerships between research institutes and companies to translate fundamental glycomics research into commercial biopharmaceutical applications as well as expanding the market into non-biomedical sectors involving industrial product development and quality control.

Key Features of the Study:

• This report provides an in-depth analysis of the global glycomics market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global glycomics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study includes RayBiotech Life, Inc., Shimadzu Corporation, Asparia Glycomics, Agilent Technologies Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Merck KgaA, New England Biolabs, Takara Bio Inc, Waters Corporation, Danaher, Lectenz Bio, GlycoMimetics, Inc., Ludger Ltd., GlycoTech Corporation, Glycosyn LLC, and Glykos, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global glycomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycomics market

 Market Segmentation

• By Product Type:
• • Reagents
  • Enzymes
  • Kits
  • Equipment
• By Application:
• • Diagnostics
  • Drug Discovery & Development
  • Others
•  By End User:
• • Biopharmaceutical Companies
  • Academic & Research Institutes
  • CROs
  • Others
• By Region:
• • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
• • RayBiotech Life, Inc.
  • Shimadzu Corporation
  • Asparia Glycomics
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific, Inc.
  • Bruker Corporation
  • Merck KgaA
  • New England Biolabs
  • Takara Bio Inc
  • Waters Corporation
  • Danaher
  • Lectenz Bio
  • GlycoMimetics, Inc.
  • Ludger Ltd.
  • GlycoTech Corporation
  • Glycosyn LLC
  • Glykos, Inc.